About

Element Science focuses on developing health technology aimed at preventing sudden cardiac arrest. Its main product, Jewel®, is a wearable defibrillator that offers continuous protection for users at risk of cardiac events. Although Jewel® is not yet available for purchase in the U.S., it represents a significant advancement in medical devices. The company targets individuals who are at risk, which includes millions globally, and plans to generate revenue through the sale of these devices to consumers, healthcare providers, and insurance companies. Element Science distinguishes itself from competitors by prioritizing diversity, equity, inclusion, and belonging within its workforce, reflecting its commitment to positive societal impact. Additionally, the company is in a growth phase, actively expanding its team, which may enhance its market presence and revenue potential in the medical technology field.

Simplify's Take

What believers are saying

• Element Science raised $145.6M in Series C funding, supporting product development and expansion.
• The global wearable medical device market is projected to grow at a 26.8% CAGR.
• FDA's expedited approval process could accelerate Jewel® defibrillator's market entry.

What critics are saying

• Delay in FDA approval could hinder Jewel® defibrillator's U.S. market entry.
• Intensifying competition from companies like Zoll Medical may impact market share.
• Semiconductor shortages could delay Jewel® device production and distribution.

What makes Element Science unique

• Element Science's Jewel® defibrillator offers 24/7 protection for high-risk cardiovascular patients.
• The company integrates machine learning with clinical-grade wearables for personalized patient care.
• Element Science emphasizes DEIB, enhancing its workplace culture and innovation potential.

Help us improve and share your feedback! Did you find this helpful?

YesNo